Department of Radiotherapy, First Hospital of Shanxi Medical University, Taiyuan, China.
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technolgy, Wuhan, China.
Mini Rev Med Chem. 2023;23(10):1072-1078. doi: 10.2174/1389557522666220905090732.
Multidrug Resistance (MDR) in tumor cells, a phenomenon in which tumor cells become resistant to chemotherapeutic drugs with different chemical structures and mechanisms of action, is a major obstacle to tumor therapy and is an urgent problem to be addressed. Autophagy, widely found in eukaryotic cells, is a lysosome-dependent pathway of self-degradation. In different environments, autophagy can play different roles in the self-protection of cells. At different stages of tumorigenesis, autophagy can play two distinct roles: inhibition of cancer and promotion of cancer. The relationship between autophagy and drug resistance in tumor cells is complex. Moreover, autophagy can play a role in promoting drug resistance and drug sensitivity through different molecular pathways. This study aimed to investigate the relationship between autophagy and drug resistance in tumor cells from the perspective of molecular mechanisms.
肿瘤细胞的多药耐药性(MDR)是指肿瘤细胞对具有不同化学结构和作用机制的化疗药物产生耐药性,这是肿瘤治疗的主要障碍,也是亟待解决的问题。自噬广泛存在于真核细胞中,是一种依赖溶酶体的自我降解途径。在不同的环境中,自噬可以在细胞的自我保护中发挥不同的作用。在肿瘤发生的不同阶段,自噬可以发挥两种截然不同的作用:抑制癌症和促进癌症。自噬与肿瘤细胞耐药性之间的关系非常复杂。此外,自噬可以通过不同的分子途径在促进耐药性和药物敏感性方面发挥作用。本研究旨在从分子机制的角度探讨自噬与肿瘤细胞耐药性之间的关系。